Reversal of Multidrug Resistance in an Epirubicin-Resistant Gastric Cancer Cell Subline
Aledson Vitor Felipe1,2, Juliana de Oliveira, Andrea Aparecida Moraes
1Department of Medicine, Gastroenterology Division, Federal University of Sao Paulo, Brazil.
Abstract:
Background: Gastric cancer is one of the most common malignancies worldwide. Epirubicin (EPI) is used extensively in the treatment of multiple cancers despite its tendency to induce multidrug resistance though overexpression of the ABCB1 efflux pump. However, this overexpression can be disrupted using short interfering RNAs (siRNAs). Objective and Methods: The aim of this study was to explore approaches to reverse EPI resistance and thus increase the success of chemotherapy treatment in an EPI-resistant gastric cancer cell subline (AGS/EPI). Methods: The study focused on effects of ABCB1 knockdown by siRNA technology using TaqMan gene expression assays with quantitative real-time reverse-transcription PCR (qRT-PCR). MTT assays were performed to evaluate viability and prolifer in subline. ABCB1 protein localization and EPI intracellular fluorescence intensity in AGS/EPI cells were detected by confocal microscopy. Results: The siRNA efficiently downregulated ABCB1 mRNA in AGS/EPI cells. Thus MDR reversal was clearly demonstrated in the AGS/EPI cells, offering the possibility of future in vitro chemoresistance assays for the GC field. Conclusions: ABCB1 knockdown decreased EPI efflux and increased EPI sensitivity in AGS/EPI cells. This result provides a novel strategy for targeted gene therapy to reverse EPI resistance in gastric cancer.
Insights
Short interfering RNAs (siRNAs) effectively reduced ABCB1 gene expression in gastric cancer cells, overcoming epirubicin resistance. This targeted gene therapy approach enhances chemotherapy effectiveness by increasing drug sensitivity.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Gastric cancer is a prevalent malignancy globally.
- Epirubicin (EPI) is a key chemotherapy drug, but its efficacy is limited by multidrug resistance (MDR) due to ABCB1 efflux pump overexpression.
- ABCB1 overexpression can be targeted by short interfering RNAs (siRNAs).
Purpose of the Study:
- To investigate methods for reversing epirubicin resistance in gastric cancer.
- To enhance chemotherapy success by targeting ABCB1 in an epirubicin-resistant gastric cancer cell line (AGS/EPI).
Main Methods:
- Utilized siRNA technology for ABCB1 knockdown in AGS/EPI cells.
- Employed quantitative real-time reverse-transcription PCR (qRT-PCR) for gene expression analysis.
- Assessed cell viability and proliferation using MTT assays.
- Visualized ABCB1 protein and epirubicin (EPI) intracellular localization via confocal microscopy.
Main Results:
- siRNA successfully downregulated ABCB1 mRNA levels in AGS/EPI cells.
- Demonstrated significant reversal of multidrug resistance (MDR) in the treated cells.
- Observed decreased EPI efflux and increased EPI sensitivity in AGS/EPI cells post-ABCB1 knockdown.
Conclusions:
- ABCB1 knockdown using siRNA is a viable strategy to overcome epirubicin resistance in gastric cancer.
- This approach offers a novel targeted gene therapy for enhancing chemotherapy outcomes in gastric cancer patients.
- The findings support the development of in vitro chemoresistance assays for gastric cancer research.
More Related Videos
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
Related Concept Videos
Treatment Resistant Cancers
Resistivity
Resistance
Equivalent Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...
